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Abstract: The biochemical activity and morphology of control and streptozotocin-diabetic rat liver Golgi complexes were
previously investigated by us under influence of some vanadium [V(IV)] compounds. The effectiveness of these derivatives
depends on the kind of complexing ligands. This paper presents the investigation of the effect of bipyridyl, the ligand of a
new vanadium compound, tested by us with maltol and kojic acid (two ligands studied by the present and other authors).
The three ligands alone action was tested under the same experimental conditions as in the case of whole compounds with
vanadium and applied to liver Golgi complexes of control rats. A preliminary study for maltol and kojic acid had been pre-
viously carried out by us parallel with tests of whole vanadium complexes, but valuable differences in biological action
found in our condition of experiments suggested the extension of studies to include the two above-mentioned ligands and
to compare the effects of the three investigated ligands. The supplementary part of the experiment focused mainly on the
ultrastructure of Golgi complexes in hepatocytes. Four groups of animals were used: C - control rats, C + M (maltol), C +
(ka)2 (kojic acid) and C + (bpy)2 (bipyridyl). The control rats received 0.09M NaCl as drinking liquid; all the other animals
were given 3.6 mmol/L of appropriate ligand solution in 0.09M NaCl during 7 days. All the animals survived the experi-
ments. Only in group C + (bpy)2 did the authors observe statistically significant differences as compared with the controls
(group C). The differences were detected in physiological studies and manifested as body weight decreased by approxi-
mately 20% during the experiment, lower liquid (p<0.001) and food (p<0.01) intake and increase of free blood sugar level
(p<0.01). The yield of Golgi membrane isolation decreased in this group (p<0.01). The main investigated biochemical
parameter, i.e. the activity of liver Golgi marker enzyme - galactosyltransferase - was not statistically significantly changed
in comparison with the controls in all the investigated groups of rats; a similar dispersion of individual results were found
in the four groups. In the three experimental groups, ultrastructural observations demonstrated a predominance of cylindri-
cal Golgi structures, which were haphazardly twisted in the majority of cases. Typically shaped structures were encountered
sporadically. The ligands alone evoked numerous subcellular changes in hepatocytes; these alterations most frequently
involved the mitochondria and endoplasmic reticulum. No such changes had been seen, or else they had been less advanced
when complex vanadium compounds were employed in our earlier experiments. As it follows, the ligands alone were
demonstrated to be much more toxic to morphology of control liver Golgi apparatus as compared to complex compounds,
which showed the ability of the former to normalize Golgi complexes of diabetic animals.
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Introduction
In the previous study of experimental diabetes induced
in rats by single intraperitoneal injections of streptozo-
tocin (STZ), we found characteristic changes of the
biochemical activities and morphology of rat liver
Golgi complexes [1-3]. These changes were so charac-
teristic for the model of this disease, that we used them
in subsequent investigations as a convenient test of
cytoprotective [4,5] or normalizing [6-9] properties of
various drugs tested. Within the past years, we were
especially interested in the effect of bis(oxalate)oxo-
vanadium(IV) [8,9], bis(maltolato)oxovanadium(IV)
[BMOV] [6,10], bis(kojato)oxovanadium(IV) [VO(ka)2]
[7,11] and bis(2,2'-bipyridine)oxovanadium(IV)
[VO(bpy)2] [12,13] as anti-diabetic drugs. The best
properties in normalizing diabetic symptoms in our
model diabetes were shown by BMOV [6,10]. This
result was in agreement with data provided by other
authors, who carried out various physiological and
biochemical studies under experimental conditions
other than those employed by us and found the effect
of BMOV to be superior to that of vanadium kojate or
vanadyl sulfate [14,15]. Two vanadium(IV) complex-
es: bis(oxalate)- and bis(2,2'bipyridine)oxovanadi-
um(IV) constituted new, hitherto not tested vanadium
complexes; however, in our experiments, they were
also proven to be less effective than BMOV. In dia-
betic animals, they caused an "improving" effect only
in the morphology of Golgi complexes structure.
Since along with diabetic groups, parallel investiga-
tions of control rats were always carried out under
identical experimental conditions (the same batch of
rats, the same time and the same concentrations of
vanadium compound solution), we found that the
three investigated vanadium(IV) complexes acted in
a different way on liver Golgi apparatus in healthy
animals. The fact prompted an investigation of the
influence of three ligands (which we previously used
to obtain whole complexes with vanadium) acting
alone under our experimental conditions. This paper
presents the results obtained by application of
bipyridyl [(bpy)2] and compares them with prelimi-
nary result of maltol (M) [6] or kojic acid [(ka)2] [11]
acting alone, the latter being employed in control rat
liver Golgi apparatus over the same time and at the
same concentrations as in the case of the whole com-
plex with vanadium(IV).
Materials and Methods
Animals. Four groups of approximately 6-month old of female
inbred Wistar rats, weighing 210-240 g were used in experiments
by permission of the Cracow Ethics Commission for Animal
Experiments. The rats were fed with pelleted food and tap water
prior to experiments. During experiments, the animals received
0.09 M NaCl or one of the three ligand solutions dissolved in
0.09 M NaCl (because in complexes with vanadium the solution
was previously used to diminish their toxicity) as described
below. Concentrations of the ligands were the same as in com-
plexes with vanadium. The solutions were freshly prepared every
two days.
Group C - control animals, receiving 0.09 M NaCl as drinking
solutions for 7 days. This group consisted of all the control rats,
investigated in subgroups of 5 to 7 animals parallel with the rats
from the other three experimental groups; for this reason, the num-
ber of animals was higher than in the other groups (20 rats).
Group [C+M] - The rats received 3.6 mmol/L maltol solution
in 0.09 M NaCl as drinking liquid for 7 days (9 rats).
Group [C+ (bpy)2] - The rats received 3.6 mmol/L bipyridyl
solution in 0.09 M NaCl as drinking solution for 7 days (11 rats).
Group [C+ (ka)2] - The rats treated with 3.6 mmol/L kojic acid
in 0.09 M NaCl as drinking solution for 7 days (9 rats). 
All the animals survived the experiments. The rats were not
fasted before sacrificing to eliminate factors other than ligands
that might have influenced the animals. The rats were weighed
each day, and the amounts of drinking liquid and food consumed
by the animals were measured. On the last day of the experi-
ment, liver samples for morphological analysis were taken under
general anesthesia, and the livers immediately used for isolation
of Golgi membranes followed by estimation of GalT activity
[16]. Morbital (pentobarbitalum) administered intraperitoneally
at the dose of 1 ml/100 g of body weight was used as an anes-
thetic drug. The blood was collected from the hepatic vein with
a heparinized syringe.
Analytical methods. The free blood sugar level was estimated
according to Somogyi and Nelson [17]. Protein was estimated by
the method of Lowry et al. [18] with crystalline serum bovine albu-
min as the standard. The Golgi-rich membrane fraction was isolat-
ed and galactosyltransferase (GalT) activity estimated according to
the Fleischer method [16].
Ultrastructural examination. For electron microscopy, two to
four biopsy specimens from each group were fixed in formalde-
hyde-glutaraldehyde fixative overnight at 4°C with the method of
Karnovsky [19]. The tissue was subsequently postfixed in 1%
osmium tetroxide. After dehydration in graded concentrations of
ethyl alcohol and propylene oxide, the tissue was embedded in
Spurr medium. Samples were sectioned with an ultramicrotome
Reichert Ultracut S using a diamond knife. Semi-thin sections were
stained with methylene blue and ultra-thin sections, with 8%
uranyl acetate dissolved in 50% methanol and then in lead citrate
according to Venable and Coggeshal [20]. All studies were per-
formed under an electron microscope (Zeiss EM 900) operating at
80kV. Electronograms had primary magnification of 20 000×.
Statistical analysis. All the results expressed as mean ± SD
were tested for statistical significance by Student's t-test. Statis-
tically significant values (p<0.05) are marked below the Table 1
or in the text.
Reagents. Sodium cacodylate, serum bovine albumin, TRIS and  
β-mercaptoethanol came from Koch-Light Lab., UDP-Gal, Tri-
ton X-100, streptozotocin, maltol, bipyridine, kojic acid and
Dowex 2x8 (200-400 mesh) were obtained from Sigma Chemi-
cal Co., 14C UDP-Gal with specific activity 292 mCi/mmol was
obtained from Radiochemical Centre Amersham, morbital (pen-
tobarbitalum) came from Biowet (Pu³awy, Poland). All other
reagents were purchased in analytical grades from Polish Chem-
ical Reagents POChem Gliwice. For electron microscopy, uranyl
acetate and lead citrate were obtained from Sigma Chemical Co.,
Spurr epoxy resin from Pelco Co., and formaldehyde, glu-
taraldehyde and sodium tetroxide were purchased from Poly-
sciences Inc.
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Results
Table 1 summarizes some physiological and biochem-
ical parameters in the four investigated groups of rats.
In the C+M group, the biochemical results similar to
control values were obtained. Total galactosyltrans-
ferase (GalT) activity in this group expressed in
nmoles Gal transferred per h and per whole liver
(which express the liver glycosylation potency) was
the highest among all the investigated groups (Table
1), but statistically non-significant, similarly as the
enzyme activity calculated per 1 g of liver (Fig 1). This
result was in agreement with our preliminary morpho-
logical study [6], which showed some stimulation of
secretory activity. 
The treatment of the control rats with bipyridyl
[group C+(bpy)2] caused the greatest alterations of the
investigated parameters both in physiological and bio-
chemical studies (except GalT activity), especially
pronounced in an approximately 20% decrease in body
weight and statistically significant diminished liquid
(p<0.001) and food (p<0.01) intake during the experi-
ment. In this group, the free blood sugar level was ele-
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Table 1. Some physiological and biochemical characteristics of investigated rats and isolated rat liver Golgi-rich membrane preparations.
n = number of animals, GalT = galactosyltransferase, 
The data are represented as the mean value ± SD. In comparison with group C, the t and p values were: a t=2.141, 0.02<p<0.05, b t=7.001, p<0.001,  t=3.645,
c 0.001<p<0.01, d t=3.571, 0.001<p<0.01, e t=3.094, 0.001<p<0.01, 
Dispersion of individual results of activity of GalT calculated as nmoles Gal transferred per h and per g of liver is presented in Fig 1.
Fig. 1. Dispersion of results of galactosyltransferase activity
(expressed as nmoles Gal transferred per 1 hour and per g of liver).
In all the groups, values and dispersion of results were similar to
the controls. The results of specific and total activities of this
enzyme are given in Table 1.
vated as compared to the controls (p<0.01), what had
never been observed in either of the investigated
groups treated with a whole vanadium with ligands
compound [6-13,21,22] or ligands alone. The bio-
chemical study showed that the yield of isolation of
Golgi-rich membrane fraction was the lowest in group
C+(bpy)2, and - in comparison to group C - statistical-
ly significant (p<0.01). The changes in the activity of
the Golgi marker enzyme, i.e. galactosyltransferase
(GalT), were statistically non-significant in all the
experimental groups as compared to the controls, irre-
spectively of the employed calculation methods: as
specific (expressed as nmoles Gal transferred per h and
per mg of protein) or total activity (in nmoles Gal
transferred per h and total liver) Table 1. The disper-
sion of results in individual rats (in nmoles Gal trans-
ferred per h and per g of liver) was similar in the four
investigated groups as presented in Fig. 1. 
The animals treated with kojic acid [group C+(ka)2]
did not show alterations in physiological and biochem-
ical parameters, the mean value of total GalT activity
was the lowest of the four investigated groups, but the
difference was statistically non-significant.
Figures 2a, b, c, d present electron microscopic
examinations of Golgi complex regions in rat hepato-
cytes. Fig. 2 a shows a control rat liver, untreated with
drugs. The morphological investigation carried out in
the maltol-treated group showed considerable ultra-
structural abnormalities of Golgi complexes. In the
majority of cases, the cisternae were irregularly twist-
ed, leading to chaotic images seen in the cross-sections
(Fig. 2b). In the group of rats that received kojic acid,
the hepatocytes demonstrated the presence of small
Golgi structures with irregularly bent, narrow, bifur-
cated cisternae. In the vicinity of such structures,
small, coated vesicles were seen, along with dense-
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Fig. 2. The region of Golgi complexes in the rat hepatocytes from: a. Control rats. On the trans side - close to Golgi stack - a large vac-
uole is visible. The bar represents 0.5μm (magnification ×20 000). b. Maltol treated rats. A large, round, irregularly shaped Golgi com-
plex is surrounded by lysosome-like structures. The bar represents 0.5μm (magnification ×20 000). c. Kojic acid treated rats. A small
sized, irregularly shaped Golgi complex. In the vicinity, small coated and dense-core vesicles are seen. The bar represents 0.5μm (mag-
nification ×20 000). d. Bipyridyl treated rats. Aggregates of electron-lucent vacuoles surrounded by narrow cisterns of round Golgi appa-
ratus. The bar represents 0.5μm (magnification ×20 000).
core type vesicles (Fig. 2c). This group showed the
lowest prevalence of vacuoles enclosed in a double
membrane. In the bipyridyl group, electron
microscopy showed changes of rat liver Golgi struc-
tures. The predominating type of Golgi complexes was
markedly arched or oval in shape (Fig. 2d).
Discussion
Vanadium shows various biological, pharmacological
and therapeutic activities, such as insulin-mimetic,
cytotoxic, genotoxic, anti- or pro-carcinogenic; it
affects the activity of many enzymes, lowers choles-
terol, triglycerides and glucose levels, exerts diuretic
and natriuretic effects, as well as enhances oxygen-
affinity of hemoglobin and myoglobin [23-26]. In
addition to such variables as the strain of experimental
animals or cells, as well as the method of application
and duration of experiments, the kind of ligands used
to obtain appropriate vanadium complexes is of a great
importance, because the efficacy and toxic side effects
of such complexes depend on the ligands themselves. 
Thompson and Orvig [27] review the most impor-
tant organic vanadium ligands that have been already
employed in various investigations as potential "anti-
diabetic agents". The key problem here is the incorpo-
ration of results obtained while investigating animal
models to therapeutic management of diabetes in
humans. Inasmuch as the physico-chemical properties
of these compounds and their pharmacology and toxi-
city are fairly well known, studies on the effect of lig-
ands as such on physiological, biochemical and phar-
macological parameters investigated by various
authors in various models are relatively obscure. This
is particularly true in the case of experiments carried
out at the subcellular level. In our model, we investi-
gated the behavior of Golgi complexes, an organelle
that is responsible for protein and lipid glycosylation
(the metabolism of which is altered in diabetes) in
hepatocytes. Some authors [15,27-29] emphasize the
fact that in the case of organic vanadium derivatives, a
decisive factor that determines the effectiveness of the
activity may be the ligand itself and this is why they
advocate the employment of non-toxic ligands, with
maltol or ethyl maltol considered prime examples.
The anti-hyperglycemic effect of various cations,
such as vanadium, tungsten, molybdenum, cobalt,
zinc, chromium or copper, on some metabolic alter-
ations in diabetes were described [30,31]. The effec-
tiveness of these complexes as anti-diabetic drugs
depends, rather than on the kind of cations, on ligands
used in these cations chelating [14,15,24]. In our
experimental model, i.e. the study of the rat liver Golgi
complexes as an indicator of alterations caused by
STZ-diabetes, we found diversified effects of V(IV)
and V(V) vanadium complexes on the control and
STZ-diabetic rats [4-7,9-15,21,22]. These effects
depended on the kind of ligands used, such well known
[2-4,7,8,13-16,28,31], as in new vanadium derivatives
[8,9,12,13]. We decided to investigate the effect of three
organic ligands alone on biochemical activity and mor-
phology of Golgi complexes in control rat livers. The
ligands were used in the same concentration and under
the same experimental conditions as in the case of
experiments with whole vanadium derivatives.
In physiological investigations, during the experi-
ment only bipyridyl did cause a statistically significant
decrease of weight (p<0.05) and liquid (p<0.001) and
food (p<0.01) intake as compared to the controls. As it
follows from our experiments, bipyridyl - contrary to
kojic acid and maltol - changes physiological parame-
ters without affecting galactosyltransferase activity.
One may thus surmise that the glycosylation potential
(total GalT activity) has been preserved.
Morphological investigations showed changes in
rat liver Golgi structures. Rats receiving one of the lig-
ands alone, demonstrated intermediate subcellular
changes of the Golgi apparatus region. The most
astonishing fact was the presence of oval Golgi appa-
ratus cisternae in more than 85% of the cases: triple,
double or single narrow cisternae surrounded multiple
and large vacuoles, either electron-lucent or filled with
flocculent material. In the vicinity, lysosome-like
structures and vesicles were seen. It seems that ligand
alone was also not as effective as a corresponding
complex compound in normalizing biochemical and
morphological parameters. In addition, it had cytotox-
ic properties, leading to damage of other cellular
organelles. 
In conclusion, it seems that the new compound
VO(bpy)2, although it does normalize the investigated
selected parameters, in view of its toxicity [12,13] and
the effect of bipyridyl itself, will be of a limited use
and most likely will not be commonly employed as a
"drug" in humans, the more so that -as it has been
emphasized by Thompson and Orvig [27] to date, the
best compounds include BMOV (maltol derivatives)
and BEOV (ethyl maltol compounds), in which the
very ligands are non-toxic to man. 
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